Speech therapy of dysarthria in Parkinson's disease

被引:0
|
作者
Cabrejo, L
Auzou, P
Ozsancak, C
Hannequin, D [1 ]
机构
[1] CHU Charles Nicolle, Dept Neurol, F-76000 Rouen, France
[2] Grp Hopale, Serv Explorat Fonct Neurol, Berck Sur Mer, France
[3] CHRU, Serv Neurol, F-59 Lille, France
来源
PRESSE MEDICALE | 2003年 / 32卷 / 37期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Speech therapy of dysarthria in Parkinson's disease. The treatment of speech impairment a factor of loneliness, speech therapy to treat dysarthria in Parkinson's disease is a fundamental aspect of patient management. The impact of medicinal treatment of dysarthria is controversial and surgery appears to worsen the problem. Various speech therapy approaches are relaxation, postural rehabilitation, respiration, phonation, articulation and prosodic re-education. An interesting method: This overview underlines the fundamental principles of speech therapy in Parkinson's disease and compares the main methods and their results. We particularly insist on the Lee Silverman Voice Treatment (LSVT), phonation re-education method that has been widely developed in the United-States. Our aim is to provide better knowledge on this re-education method in France.
引用
收藏
页码:1745 / 1751
页数:7
相关论文
共 50 条
  • [41] Music therapy in voice and speech disorders in patients with Parkinson's disease
    Habalova, M.
    Lucka, Z. Fabry
    Hornakova, M.
    Csefalvay, Z.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (02) : 141 - 146
  • [42] Drooling in Parkinson's disease: A novel speech and language therapy intervention
    Marks, L
    Turner, K
    O'Sullivan, J
    Deighton, B
    Lees, A
    [J]. INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS, 2001, 36 (02) : 282 - 287
  • [43] Quality Indicators for Speech-Language Therapy in Parkinson's Disease
    Kalf, J. G.
    Munneke, M.
    [J]. MOVEMENT DISORDERS, 2010, 25 : S711 - S712
  • [44] Barriers to Adherence to Physical Therapy, Occupational therapy, and Speech/Swallowing Therapy in Parkinson's Disease
    Vurture, Gregory W.
    Kulick, Catherine V.
    Montgomery, Kathryn M.
    Nirenberg, Melissa J.
    [J]. NEUROLOGY, 2018, 90
  • [45] The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson's disease: A review of the literature
    Schulz, GM
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (14) : 1359 - 1366
  • [46] Assessment of dysarthria in patients with Parkinson's disease, using the "Frenchay dysarthria assessment, (FDA-2)"
    Nasios, G.
    Kandri, A.
    Tafiadis, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 543 - 543
  • [47] Speech disfluencies in Parkinson's disease
    Polrola, Pawel J.
    Goral-Polrola, Jolanta
    [J]. MEDICAL STUDIES-STUDIA MEDYCZNE, 2015, 31 (04) : 262 - 270
  • [48] Emotional speech in Parkinson's disease
    Moebes, Janine
    Joppich, Gregor
    Stiebritz, Frank
    Dengler, Reinhard
    Schroeder, Christine
    [J]. MOVEMENT DISORDERS, 2008, 23 (06) : 824 - 829
  • [49] Speech rate in Parkinson's disease
    Skodda, S. K.
    Visser, W.
    Schlegel, U.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S75 - S76
  • [50] Speech and swallowing in Parkinson's disease
    Tjaden, Kris
    [J]. TOPICS IN GERIATRIC REHABILITATION, 2008, 24 (02) : 115 - 126